CS-32582

N/A

Report date: 2025/07/14 20:01:16
NME

Base Information

Drug NameCS-32582
Drug Alias NameCS-32582CS32582
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase 2 inhibitors
TargetsTyrosine-protein kinase 2
Therapy Area/IndicationsPlaque psoriasisAutoimmune DiseasesPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShenzhen Chipscreen Biosciences Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChengdu Chipscreen Pharmaceutical Co LtdChipscreen Biosciences Ltd
Inactive CompaniesShenzhen Chipscreen Biosciences Co Ltd
Active IndicationsPlaque psoriasisPsoriasis
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A